Kalobios Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Kalobios Pharmaceuticals Inc
TickerHGEN
CIK #0001293310
CUSIP444863104
SectorLife Sciences - Pharmaceutical Preparations
Address260 East Grand Ave, South San Francisco, CA 94080
Source [EDGAR]
CIK Filing 2011 - 2025
[0001293310] 10-K
[0001293310] 10-Q
[0001293310] 3
[0001293310] 4
[0001293310] 5
[0001293310] 8-K
[0001293310] D
[0001293310] SC 13D
[0001293310] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
BlackRock Inc Humanigen Inc [2022-05-09] 4.7
BlackRock Inc Humanigen Inc [2022-02-04] 5.2
Murchinson Ltd Humanigen Inc [2021-12-30] 7.02
State Street Corp Humanigen Inc [2021-10-12] 14.82
Valiant Capital Management LP Humanigen Inc [2020-06-12] 12.9
Venrock Healthcare Capital Partners II LP Humanigen Inc [2020-06-12] 8.3
Nantahala Capital Management LLC Kalobios Pharmaceuticals Inc [2017-02-14] 0.7
DHAR Kapil Kalobios Pharmaceuticals Inc [2016-08-16] 6.37
Nomis Bay Ltd Kalobios Pharmaceuticals Inc [2016-07-13] 24.95
Black Horse Capital LP Kalobios Pharmaceuticals Inc [2016-07-11] 5.9
Moradi David Kalobios Pharmaceuticals Inc [2015-12-18] 14.02
Shkreli Martin Kalobios Pharmaceuticals Inc [2015-11-25] 70.1
First Eagle Investment Management LLC Kalobios Pharmaceuticals Inc [2015-01-29] 5.29
Alloy Ventures 2000 LP Kalobios Pharmaceuticals Inc [2014-02-14] 5.1
MPM BioVentures III LP Kalobios Pharmaceuticals Inc [2014-02-13] 0.4
Sofinnova Venture Partners V LP Kalobios Pharmaceuticals Inc [2014-02-12] 8.5
Flynn James E Kalobios Pharmaceuticals Inc [2014-02-05] 9.64
Lehman Brothers Holdings Inc Kalobios Pharmaceuticals Inc [2013-02-14] 4.4
Baxter International Inc Kalobios Pharmaceuticals Inc [2013-02-13] 27.99
FMR LLC Kalobios Pharmaceuticals Inc [2013-02-11] 0.0
Vanguard Group Inc Kalobios Pharmaceuticals Inc [2013-02-11] 10.3
Development Bank of Japan Inc Kalobios Pharmaceuticals Inc [2013-02-08] 16.6
PRIMECAP Management Co/CA/ Kalobios Pharmaceuticals Inc [2013-02-04] 15.76
Form 3/4/5 Filer 2011 - 2025
Humanigen Inc
Kilcoyne Adrian
Buxton Cheryl
Hohneker John
Barliant Ronald
Chappell Dale
Boehm Rainer J.
Jordan Edward P.
Morris Timothy E
Xie Yili Kevin
Durrant Cameron
Black Horse Capital Master Fund Ltd.
Black Horse Capital LP
Black Horse Capital Management LLC
Cheval Holdings, Ltd.
Nomis Bay Ltd
Tousley David L.
Savage Robert G.
Jester J Gregory
Lam Morgan
Friedberg Ezra M
Shkreli Martin
Witter Dean III
Harrison Michael Wayne
Fernandez Thomas Edward
Biestek Marek
Anthion Partners II LLC
Moradi David
Chase Anthony R
Cross Herb
Martell Ron
Gilbert Denise
Love Ted W
Lyons Gary A
Smaldone Alsup Laurie
Withy Raymond M
Baffi Robert
Joseph Donald
Yarranton Geoffrey Thomas
Lawlis V Bryan
Pritchard David
Molfino Nestor
Smith Brigitte
Henner Dennis
Healy James
Cooper Jeffrey H
5AM Partners LLC
Development Bank of Japan Inc
Mitsubishi UFJ Capital II, Limited Partnership
Baxter International Inc
GBS Bioventures II A/C
Genesis Fund
GBS Venture Partners Pty, Ltd
Alloy Annex I, LLC
Alloy Corporate 2000, L.P.
Alloy Partners 2000, L.P.
Alloy Ventures 2000, L.P.
Alloy Investors 2000, L.P.
Alloy Ventures 2000, LLC
Alloy Annex I, L.P.
Sofinnova Venture Partners V LP
Sofinnova Management V LLC
Sofinnova Venture Affiliates V LP
Sofinnova Venture Principals V LP
Powell Michael
Sofinnova Management V 2005, LLC
Azan Alain
Lehman Brothers Holdings Inc.
EDB Investments Pte Ltd.
Singapore Bio Innovations PTE Ltd
Sanofi
MPM BioVentures III LP
MPM BioVentures III GP LP
MPM BioVentures Iii-Qp LP
MPM BioVentures III LLC
MPM BioVentures Strategic Fund LP
MPM BIOVENTURES III GMBH & CO. Beteiligungs KG
MPM BioVentures III Parallel Fund LP
MPM Asset Management Investors 2005 BVIII LLC
Evnin Luke
Gadicke Ansbert
Simon Nicholas J III
Galakatos Nicholas
Steinmetz Michael
Wheeler Kurt
5AM Ventures LLC
5AM Co Investors LLC
Shochat Dan
Lehman Brothers Holdings Inc Plan Trust
Form 13F Holdings
Firm Period DFND Voting Shares
BlackRock Inc. [2023-03-31] SOLE 1,023,452.0 1,025,320.0
Bank of New York Mellon Corp [2023-03-31] DFND 884,433.0 884,433.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 683,489.0
Geode Capital Management LLC [2023-03-31] DFND 482,363.0 482,363.0
UBS Group AG [2023-03-31] DFND 0.0 322,732.0
State Street Corp [2023-03-31] DFND 188,676.0 188,676.0
Two Sigma Investments LP [2023-03-31] SOLE 169,137.0 169,137.0
Northern Trust Corp [2023-03-31] DFND 0.0 140,542.0
Renaissance Technologies LLC [2023-03-31] SOLE 97,700.0 97,700.0
Morgan Stanley [2023-03-31] DFND 57,914.0 63,214.0
Captrust Financial Advisors [2023-03-31] SOLE 61,000.0 61,000.0
Tower Research Capital LLC (TRC) [2023-03-31] DFND 52,526.0 52,526.0
Two Sigma Securities LLC [2023-03-31] SOLE 52,477.0 52,477.0
Sheaff Brock Investment Advisors LLC [2023-03-31] SOLE 0.0 46,000.0
AE Wealth Management LLC [2023-03-31] SOLE 0.0 39,450.0
Citadel Advisors LLC [2023-03-31] DFND 31,576.0 31,576.0
Valeo Financial Advisors LLC [2023-03-31] SOLE 30,000.0 30,000.0
Onyx Bridge Wealth Group LLC [2023-03-31] SOLE 0.0 28,037.0
Group One Trading LP [2023-03-31] SOLE 26,265.0 26,265.0
HRT Financial LP [2023-03-31] DFND 26,108.0 26,108.0
Vanguard Personalized Indexing Management, LLC [2023-03-31] SOLE 17,703.0 17,703.0
Vanguard Group Inc [2023-03-31] DFND 0.0 17,311.0
Triumph Capital Management [2023-03-31] SOLE 0.0 17,000.0
Millennium Management LLC [2023-03-31] SOLE 16,989.0 16,989.0
Wealth Alliance Advisory Group LLC [2023-03-31] SOLE 0.0 15,000.0
Bank of America Corp /DE/ [2023-03-31] DFND 8,510.0 13,835.0
Susquehanna International Group LLP [2023-03-31] DFND 13,768.0 13,768.0
Advisor Group Holdings Inc [2023-03-31] DFND 6,000.0 11,950.0
Raymond James & Associates [2023-03-31] SOLE 0.0 10,300.0
CIBC Private Wealth Group, LLC [2023-03-31] DFND 10,000.0 10,000.0
Prev | Page 24 | Next
Terms | Privacy | Guide
tony@aum13f.com